Iterum Therapeutics PLC Financial Flexibility Index
Iterum Therapeutics PLC financial flexibility index. Iterum Therapeutics PLC (ITRM) has a Financial Flexibility Index of -0.20x as of September 2025. Free cash flow of $-7.84 Million (operating CF $-7.85 Million minus capex $12.57K) represents 0% of total liabilities ($39.88 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Iterum Therapeutics PLC (2016–2024)
Financial flexibility index of Iterum Therapeutics PLC from 2016 to 2024. Historical Financial Flexibility Index trend for Iterum Therapeutics PLC across 9 annual periods. Check Iterum Therapeutics PLC cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Iterum Therapeutics PLC Financial Flexibility Index by Year (2016–2024)
Iterum Therapeutics PLC financial flexibility index by year from 2016 to 2024. Year-by-year free cash flow to debt coverage for Iterum Therapeutics PLC. For the full cash flow conversion analysis, see cash flow conversion of Iterum Therapeutics PLC.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.55x | $-26.77 Million | $-26.77 Million | $48.68 Million | ▲ +54.3% |
| 2023 | -1.20x | $-39.32 Million | $-39.33 Million | $32.66 Million | ▼ -153.9% |
| 2022 | -0.47x | $-18.41 Million | $-18.47 Million | $38.83 Million | ▼ -24.0% |
| 2021 | -0.38x | $-15.78 Million | $-15.84 Million | $41.27 Million | ▲ +41.5% |
| 2020 | -0.65x | $-54.52 Million | $-54.53 Million | $83.35 Million | ▲ +58.5% |
| 2019 | -1.58x | $-81.90 Million | $-81.92 Million | $51.99 Million | ▲ +45.4% |
| 2018 | -2.89x | $-75.80 Million | $-75.89 Million | $26.25 Million | ▲ +29.6% |
| 2017 | -4.10x | $-29.79 Million | $-30.60 Million | $7.26 Million | ▼ -66.2% |
| 2016 | -2.47x | $-10.49 Million | $-11.30 Million | $4.25 Million | — |